Showing results (1861-1870 of 4,541) with videos related to
Sort By:
Pageof 455
Journal of Gastroenterology|February 27, 2007
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of peripancreatic tuberculous lymphadenitisSoichi Itaba, Shigetaka Yoshinaga, Kazuhiko Nakamura, et al.Journal of Gastroenterology|March 24, 2007
Feasibility, safety, and efficacy of the Stretta procedure in Japanese patients with gastroesophageal reflux disease: first report from AsiaKazuhide Higuchi, Yasuhiro Fujiwara, Hirotoshi Okazaki, et al.Journal of Gastroenterology|February 9, 2007
Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE--famotidine or rebamipide in comparison by endoscopy)Jun-ichi Yamao, Eiryo Kikuchi, Masami Matsumoto, et al.Journal of Gastroenterology|January 24, 2007
Eradication of Helicobacter pylori for primary gastric cancer and secondary gastric cancer after endoscopic mucosal resectionMotosugu Kato, Masahiro Asaka, Shouko Ono, et al.Journal of Gastroenterology|January 24, 2007
Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseasesSusumu Take, Motowo Mizuno, Kuniharu Ishiki, et al.Journal of Gastroenterology|January 24, 2007
Toward a new classification of chronic pancreatitisGünter KlöppelJournal of Gastroenterology|January 24, 2007
Can measurement of chemokines become useful biological and functional markers of early-stage chronic pancreatitis?Tetsuhide ItoJournal of Gastroenterology|January 24, 2007
Possibility of diagnosing early-stage chronic pancreatitis by endoscopic retrograde pancreatographyTerumi Kamisawa, Masakatsu MatsukawaJournal of Gastroenterology|November 11, 2006
Changes in plasma ghrelin levels, gastric ghrelin production, and body weight after Helicobacter pylori cureHiroyuki Osawa, Hiroto Kita, Hirohide Ohnishi, et al.Journal of Gastroenterology|November 11, 2006
Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in ratsMasaru Ueki, Masahiko Koda, Satoru Yamamoto, et al.Pageof 455